Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
137 EUR | +0.13% | -1.37% | -3.35% |
28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | Other Pharmaceuticals | +0.13% | -1.37% | -3.35% | -7.90% | +11.91% | 352B | - | - | - |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Charts Johnson & Johnson
- Relative Strength Chart